“Sizable Upside Potential”: 4 Aggressive Biotech And Life Sciences Plays Under $10

“These are four stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” says the author of today’s article of the four Buy-rated biotech and life sciences stocks trading under $10 that he highlights. For these four stocks – including a developer of minimally invasive medical devices to treat obesity and metabolic diseases in the U.S. and abroad – CLICK HERE.